Stay ahead in your research with your monthly Tebubio newsletter—your go-to source for innovative reagents, expert services, and insightful articles. Curated to bring you the most relevant products, services and knowledge resources, it helps you focus on what truly matters—your research.

Human Platelet Lysate (hPL) is a xeno-free, human-derived alternative to FBS, supporting reproducible cell culture from research through clinical manufacturing with GMP-aligned quality.

Tebubio provides a comprehensive suite of tools, reagents, and custom labo services to identify, quantify, and modulate cellular senescence and SASP, supporting advanced research and therapeutic development.

Stay ahead in your research with your monthly Tebubio newsletter—your go-to source for innovative reagents, expert services, and insightful articles. Curated to bring you the most relevant products, services and knowledge resources, it helps you focus on what truly matters—your research.

Explore a range of advanced 3D cell culture platforms designed to generate physiologically relevant spheroids and organoids, supporting predictive research in oncology, imaging, and translational studies. Our technologies align with New Approach Methodologies (NAMs), helping you reduce reliance on animal models while optimising workflow reproducibility and screening outcomes.

This exclusive monthly publication #13 brings you cutting-edge advancements and premium solutions from top suppliers in Oncology. Carefully curated to keep you at the forefront of your research, each issue will put under the spotlight breakthrough products, expert-led webinars, and essential resources to support your research needs from stimulus to models to analysis solutions.

High-efficiency, ultra-low-immunogenicity mRNA mix designed to reprogram fibroblasts into iPSCs with no genomic-integration risk.

Explore advanced tools and assays from LifeSensors enabling PROTAC, molecular glue, and DUBTAC discovery. Learn how to streamline ubiquitination studies, accelerate hit validation, and empower next-generation targeted protein degradation research.

Tebubio, through iXCells Biotechnologies, delivers high-quality, physiologically relevant iPSC models from healthy, normal donors, ready to integrate seamlessly into your research.